BCI rules do not permit advertisement or solicitation by advocates or their firms. This website is for information only. See Disclaimer

Explainer: Why a recent SEBI order on Piramal Pharma was highly unusual and what it means for other listed entities

Featured in
moneycontrol



A recent piece by the moneycontrol.com sheds light on a significant development: SEBI’s rare decision to maintain its previous exoneration of Piramal Pharma Ltd in a Section 15-I(3) Review order.

Typically, SEBI’s review orders lead to increased penalties or further proceedings, however this case bucks the trend.

Mr. Sumit Agrawal, Founder of Regstreet Law Advisors and a former SEBI officer, who represented Piramal Group along with Rushin Kapadia, Kavish Garach, Anushka Fuke, highlights the rarity of this outcome. He notes that “in nearly 99.12% of cases over the past decade, SEBI’s review orders have escalated penalties or initiated further actions. This is only the second instance where SEBI, after a detailed re-examination, upheld its previous exoneration.”

This case is particularly notable for its meticulous analysis by SEBI’s Whole-Time Member as Mr. Agrawal added “Historically, SEBI has either escalated penalties or initiated further proceedings in nearly all cases—around 99.12 per cent — even after initial exoneration by the Adjudicating Officer (AO) following a thorough examination of the facts and evidence.” He added, “What’s unusual in this case is that contrary to SEBI’s standard approach of increasing penalties, the WTM undertook a detailed analysis, including a review of the entity’s materiality policy, clauses of the de-merger scheme and the impact of the events, ultimately concluding that these events were not material and did not warrant penalties”

𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐓𝐡𝐞𝐨𝐫𝐞𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐧𝐜𝐞𝐫𝐧𝐬 – could companies demerge and escape liabilities through resultant entities?

As per Mr. Sumit Agrawal this concern remains largely theoretical. He emphasizes that “a statute of limitations and clear evidence must guide SEBI’s actions, 𝒓𝒂𝒕𝒉𝒆𝒓 𝒕𝒉𝒂𝒏 𝒑𝒓𝒆𝒔𝒖𝒎𝒊𝒏𝒈 𝒕𝒉𝒂𝒕 𝒕𝒉𝒆 𝒊𝒏𝒅𝒖𝒔𝒕𝒓𝒚 𝒔𝒕𝒓𝒖𝒄𝒕𝒖𝒓𝒆𝒔 𝒎𝒆𝒓𝒈𝒆𝒓𝒔 𝒐𝒓 𝒅𝒆𝒎𝒆𝒓𝒈𝒆𝒓𝒔 𝒕𝒐 𝒆𝒔𝒄𝒂𝒑𝒆 𝒍𝒊𝒂𝒃𝒊𝒍𝒊𝒕𝒊𝒆𝒔.”

𝐁𝐫𝐨𝐚𝐝𝐞𝐫 𝐈𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐋𝐢𝐬𝐭𝐞𝐝 𝐄𝐧𝐭𝐢𝐭𝐢𝐞𝐬

He said “SEBI expects listed entities to disclose events like factory shutdowns — whether temporary or due to strikes, lockouts, fires, pollution, or court orders — and assess disclosure requirements under regulation 30 or the Business Responsibility Report, indicating a heightened focus on transparency and regulatory compliance.”

The full article can be accessed at https://lnkd.in/danagB-Y

Law enthusiasts are encouraged to share their comments or provide feedback to Regstreet Law Advisors at info@regstreetlaw.com

hashtag#SEBI hashtag#CorporateLaw hashtag#Materiality hashtag#RegstreetLawAdvisors hashtag#PiramalPharma hashtag#Exoneration hashtag#stockmarket hashtag#piramalgroup hashtag#law hashtag#lawstudents

Cateories